Filing Details

Accession Number:
0001144204-15-003361
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-22 19:34:52
Reporting Period:
2015-01-21
Filing Date:
2015-01-22
Accepted Time:
2015-01-22 19:34:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133869 Capricor Therapeutics Inc. CAPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1310611 B David Musket C/O Capricor Therapeutics, Inc.
8840 Wilshire Blvd., 2Nd Floor
Beverly Hills CA 90211
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-21 70,962 $3.52 70,962 No 4 P Indirect By SEP FBO David B. Musket, Pershing LLC as Custodian
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By SEP FBO David B. Musket, Pershing LLC as Custodian
Footnotes
  1. SEP FBO David B. Musket, Pershing LLC as Custodian, entered into a Share Purchase Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which SEP FBO David B. Musket, Pershing LLC as Custodian, on January 21, 2015, purchased an aggregate of 70,962 shares of the Issuer's common stock at a purchase price of $3.5230 per share for an aggregate purchase price of approximately US$250,000.
  2. The shares of the Issuer's common stock are held by the Reporting Person's IRA.